JP2018035082A - Emulsion composition for producing foam agent, form agent, method for improving foamability, foamability improving agent, and make-up method - Google Patents
Emulsion composition for producing foam agent, form agent, method for improving foamability, foamability improving agent, and make-up method Download PDFInfo
- Publication number
- JP2018035082A JP2018035082A JP2016168448A JP2016168448A JP2018035082A JP 2018035082 A JP2018035082 A JP 2018035082A JP 2016168448 A JP2016168448 A JP 2016168448A JP 2016168448 A JP2016168448 A JP 2016168448A JP 2018035082 A JP2018035082 A JP 2018035082A
- Authority
- JP
- Japan
- Prior art keywords
- foam
- agent
- oil
- thickener
- emulsified composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006260 foam Substances 0.000 title claims abstract description 182
- 239000000203 mixture Substances 0.000 title claims abstract description 95
- 239000000839 emulsion Substances 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title claims abstract description 37
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 69
- 239000002245 particle Substances 0.000 claims abstract description 55
- 239000012071 phase Substances 0.000 claims abstract description 51
- 239000002562 thickening agent Substances 0.000 claims abstract description 38
- 229920000642 polymer Polymers 0.000 claims abstract description 30
- 238000006068 polycondensation reaction Methods 0.000 claims abstract description 28
- 239000003380 propellant Substances 0.000 claims abstract description 18
- 239000008346 aqueous phase Substances 0.000 claims abstract description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 7
- 239000003921 oil Substances 0.000 claims description 58
- 235000019198 oils Nutrition 0.000 claims description 57
- 229920002472 Starch Polymers 0.000 claims description 32
- 239000008107 starch Substances 0.000 claims description 31
- 235000019698 starch Nutrition 0.000 claims description 31
- 229920001282 polysaccharide Polymers 0.000 claims description 30
- 239000005017 polysaccharide Substances 0.000 claims description 26
- 150000004804 polysaccharides Chemical class 0.000 claims description 25
- 239000011550 stock solution Substances 0.000 claims description 16
- 239000002537 cosmetic Substances 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 11
- 235000010443 alginic acid Nutrition 0.000 claims description 10
- 229920000615 alginic acid Polymers 0.000 claims description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 9
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 claims description 9
- 239000008158 vegetable oil Substances 0.000 claims description 8
- 150000004781 alginic acids Chemical class 0.000 claims description 7
- 239000004215 Carbon black (E152) Substances 0.000 claims description 6
- 229920000881 Modified starch Polymers 0.000 claims description 6
- 239000010696 ester oil Substances 0.000 claims description 6
- 229930195733 hydrocarbon Natural products 0.000 claims description 6
- 150000002430 hydrocarbons Chemical class 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 235000019426 modified starch Nutrition 0.000 claims description 6
- 229920002545 silicone oil Polymers 0.000 claims description 6
- 230000008719 thickening Effects 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 24
- 210000002472 endoplasmic reticulum Anatomy 0.000 abstract description 15
- 239000004129 EU approved improving agent Substances 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 description 36
- 239000007789 gas Substances 0.000 description 33
- 230000014759 maintenance of location Effects 0.000 description 33
- -1 etc.) Polymers 0.000 description 26
- 239000004088 foaming agent Substances 0.000 description 23
- 238000004945 emulsification Methods 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 229920000591 gum Polymers 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 6
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 6
- 238000009834 vaporization Methods 0.000 description 6
- 230000008016 vaporization Effects 0.000 description 6
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 5
- 239000001273 butane Substances 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 230000001804 emulsifying effect Effects 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 5
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 5
- 150000003904 phospholipids Chemical class 0.000 description 5
- 239000001294 propane Substances 0.000 description 5
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 229920002907 Guar gum Polymers 0.000 description 4
- 240000003183 Manihot esculenta Species 0.000 description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 4
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 4
- 235000019774 Rice Bran oil Nutrition 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 150000003863 ammonium salts Chemical class 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000005187 foaming Methods 0.000 description 4
- 235000010417 guar gum Nutrition 0.000 description 4
- 239000000665 guar gum Substances 0.000 description 4
- 229960002154 guar gum Drugs 0.000 description 4
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229960001679 octinoxate Drugs 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 229920001592 potato starch Polymers 0.000 description 4
- 239000008165 rice bran oil Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 3
- 235000019489 Almond oil Nutrition 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229920002148 Gellan gum Polymers 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000008168 almond oil Substances 0.000 description 3
- 239000010775 animal oil Substances 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 235000010492 gellan gum Nutrition 0.000 description 3
- 239000000216 gellan gum Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 239000008384 inner phase Substances 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 239000001879 Curdlan Substances 0.000 description 2
- 229920002558 Curdlan Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002581 Glucomannan Polymers 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000772415 Neovison vison Species 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 240000004584 Tamarindus indica Species 0.000 description 2
- 235000004298 Tamarindus indica Nutrition 0.000 description 2
- 244000250129 Trigonella foenum graecum Species 0.000 description 2
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000019316 curdlan Nutrition 0.000 description 2
- 229940078035 curdlan Drugs 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 2
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000013826 starch sodium octenyl succinate Nutrition 0.000 description 2
- 239000001334 starch sodium octenyl succinate Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000010491 tara gum Nutrition 0.000 description 2
- 239000000213 tara gum Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 2
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- FBZQBGYPONNWCG-UHFFFAOYSA-N (4,5-dihydroxy-2,3-dimethoxyphenyl)-phenylmethanone Chemical compound COC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1OC FBZQBGYPONNWCG-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- RRZWKUGIZRDCPB-UHFFFAOYSA-N 2,3-dihydroxypropyl hexanoate Chemical compound CCCCCC(=O)OCC(O)CO RRZWKUGIZRDCPB-UHFFFAOYSA-N 0.000 description 1
- IYAZLDLPUNDVAG-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 IYAZLDLPUNDVAG-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- NMUKKQFFBNEVJY-UHFFFAOYSA-K 4-O-bis[(4-oct-1-enoxy-4-oxobutanoyl)oxy]alumanyl 1-O-oct-1-enyl butanedioate Chemical compound [Al+3].CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O NMUKKQFFBNEVJY-UHFFFAOYSA-K 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 239000001884 Cassia gum Substances 0.000 description 1
- 108091005944 Cerulean Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- GLLSGHWYBGERSE-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 GLLSGHWYBGERSE-UHFFFAOYSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000019318 cassia gum Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000008260 cosmetic foam Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- BIABMEZBCHDPBV-UHFFFAOYSA-N dipalmitoyl phosphatidylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC BIABMEZBCHDPBV-UHFFFAOYSA-N 0.000 description 1
- RLPQZSVUADVLBS-UHFFFAOYSA-L disodium;3-hydroxypropyl phosphate Chemical compound [Na+].[Na+].OCCCOP([O-])([O-])=O RLPQZSVUADVLBS-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 125000004395 glucoside group Chemical group 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000003915 liquefied petroleum gas Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229940041290 mannose Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000005501 phase interface Effects 0.000 description 1
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000020233 pistachio Nutrition 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、フォーム剤作製用乳化組成物、フォーム剤、泡形成力を向上させる方法、泡形成力向上剤、及び化粧方法に関する。 The present invention relates to an emulsified composition for foam preparation, a foam agent, a method for improving foam-forming ability, a foam-forming ability improving agent, and a cosmetic method.
フォーム剤は、皮膚用化粧料、毛髪用化粧料、洗浄用品等、様々な用途で使用されており、その原液は、従来より界面活性剤による乳化組成物が用いられている。例えば、特許文献1には、所定の両性界面活性剤による乳化組成物、及び該乳化組成物と噴射剤とを含む、エアゾール型化粧料のフォーム剤が開示されている。 Foaming agents are used in various applications such as skin cosmetics, hair cosmetics, and cleaning products. Conventionally, an emulsion composition using a surfactant has been used as the stock solution. For example, Patent Document 1 discloses an emulsified composition with a predetermined amphoteric surfactant, and an aerosol-type cosmetic foam containing the emulsified composition and a propellant.
しかしながら、界面活性剤は、泡を形成する能力には優れるものの、例えば、化粧品として使用される場合には、ベトついたり、刺激が強い等の問題がある。また、フォーム剤を工業用のクリーナー等の用途として使用すると、洗浄面に界面活性剤が残ってしまい、白濁しやすくなるという問題がある。 However, although the surfactant is excellent in the ability to form foam, for example, when used as a cosmetic, there are problems such as stickiness and strong irritation. Further, when the foam agent is used as an industrial cleaner or the like, there is a problem in that the surfactant remains on the cleaning surface, and it becomes easily cloudy.
他方、上記の界面活性剤に代わる乳化技術として、自発的に閉鎖小胞体を形成する両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマーの粒子を利用した、いわゆる三相乳化法が知られている。本発明者らは、三相乳化法による乳化組成物を利用したフォーム剤において、上記の界面活性剤による問題が解決できることを見出した。しかしながら、三相乳化法では、フォーム剤として利用するには改善の余地があった。 On the other hand, as an emulsification technique to replace the above surfactant, so-called three-phase emulsification using particles of a closed vesicle or a polycondensation polymer having a hydroxyl group formed by an amphiphile that spontaneously forms a closed vesicle The law is known. The present inventors have found that the above-mentioned problems caused by the surfactant can be solved in the foam agent using the emulsion composition by the three-phase emulsification method. However, the three-phase emulsification method has room for improvement in use as a foaming agent.
したがって、界面活性剤によらずとも、十分な泡を形成できるフォーム剤が求められている。 Therefore, there is a need for a foaming agent that can form sufficient foam regardless of the surfactant.
本発明は、以上の実情に鑑みてなされたものであり、界面活性剤を用いずとも良好な泡を形成可能な新規なフォーム剤作製用乳化組成物、フォーム剤、泡形成力を向上させる方法、泡形成力向上剤及び化粧方法を提供することを目的とする。 The present invention has been made in view of the above circumstances, and is a novel foam preparation-emulsifying composition capable of forming good foam without using a surfactant, a foam agent, and a method for improving foam-forming ability. An object of the present invention is to provide a foam-forming ability improver and a cosmetic method.
本発明者らは、三相乳化により得られた乳化組成物に増粘剤を含有させることで、良好な泡を形成できることを見出し、本発明を完成するに至った。より具体的には、本発明は以下のようなものを提供する。 The present inventors have found that good foam can be formed by adding a thickener to an emulsified composition obtained by three-phase emulsification, and have completed the present invention. More specifically, the present invention provides the following.
(1) 油相、水相、自発的に閉鎖小胞体を形成する両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマーの粒子、及び増粘剤を含む、フォーム剤作製用乳化組成物。 (1) For forming a foam agent comprising an oil phase, an aqueous phase, particles of a polycondensation polymer having closed vesicles or hydroxyl groups formed by amphiphiles that spontaneously form closed vesicles, and a thickener. Emulsified composition.
(2) O/W型エマルションである、(1)に記載の乳化組成物。 (2) The emulsion composition according to (1), which is an O / W emulsion.
(3) 前記増粘剤は、水素結合によりネットワーク構造を形成した多糖類を含む、(1)又は(2)に記載の乳化組成物。 (3) The emulsion composition according to (1) or (2), wherein the thickener includes a polysaccharide having a network structure formed by hydrogen bonding.
(4) 前記多糖類が、増粘多糖類である、(3)に記載の乳化組成物。 (4) The emulsion composition according to (3), wherein the polysaccharide is a thickening polysaccharide.
(5) 前記多糖類が、デンプン、デンプン誘導体及びアルギン酸類からなる群から選択される1種以上を含む、(3)又は(4)に記載の乳化組成物。 (5) The emulsion composition according to (3) or (4), wherein the polysaccharide comprises one or more selected from the group consisting of starch, starch derivatives, and alginic acids.
(6) 前記増粘剤は、1質量%水溶液の20℃における粘度が、100mPa・s以上100000mPa・s以下である、(1)から(5)のいずれかに記載の乳化組成物。 (6) The said thickener is an emulsion composition in any one of (1) to (5) whose viscosity in 20 degreeC of 1 mass% aqueous solution is 100 mPa * s or more and 100000 mPa * s or less.
(7) 自発的に閉鎖小胞体を形成する両親媒性物質で形成された前記閉鎖小胞体の平均粒径が、8nm以上800nm以下であり、
前記重縮合ポリマーの粒子の平均粒径が8nm以上800nm以下である、(1)から(6)のいずれかに記載の乳化組成物。
(7) The average particle diameter of the closed vesicle formed of an amphiphile that spontaneously forms a closed vesicle is 8 nm or more and 800 nm or less,
The emulsion composition according to any one of (1) to (6), wherein the polycondensation polymer particles have an average particle size of 8 nm to 800 nm.
(8) 前記油相が、エステル油、炭化水素油、シリコーン油及び植物油からなる群から選択される1種以上の油を含む、(1)から(7)のいずれかに記載の乳化組成物。 (8) The emulsion composition according to any one of (1) to (7), wherein the oil phase contains one or more oils selected from the group consisting of ester oils, hydrocarbon oils, silicone oils, and vegetable oils. .
(9) (1)から(8)のいずれかに記載の乳化組成物からなる原液と、噴射剤とを含む、フォーム剤。 (9) A foaming agent comprising a stock solution comprising the emulsion composition according to any one of (1) to (8) and a propellant.
(10) 人体又は動物に適用される、(9)に記載のフォーム剤。 (10) The foam according to (9), which is applied to a human body or an animal.
(11) 油相、水相、及び自発的に閉鎖小胞体を形成する両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマーの粒子を含むフォーム剤作製用乳化組成物中に、さらに、増粘剤を含有させることにより、泡形成力を向上させる方法。 (11) In an emulsified composition for producing a foam agent, comprising an oil phase, an aqueous phase, and particles of a polycondensation polymer having a closed vesicle or a hydroxyl group formed by an amphiphile that spontaneously forms a closed vesicle Furthermore, the method of improving foam forming power by containing a thickener.
(12) 増粘剤からなる、油相、水相、及び自発的に閉鎖小胞体を形成する両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマーの粒子を含むフォーム剤作製用乳化組成物における泡形成力向上剤。 (12) Preparation of foam agent comprising particles of a polycondensation polymer having a closed endoplasmic reticulum or a hydroxyl group formed of an oil phase, an aqueous phase, and an amphiphile that spontaneously forms a closed endoplasmic reticulum, comprising a thickener. A foam-forming agent for emulsifying compositions.
(13) (9)又は(10)に記載のフォーム剤を、人体又は動物に適用する工程を有する、化粧方法。 (13) A cosmetic method comprising a step of applying the foam according to (9) or (10) to a human body or an animal.
本発明によれば、界面活性剤を用いずとも良好な泡を形成可能な新規なフォーム剤作製用乳化組成物、フォーム剤、泡形成力を向上させる方法、泡形成力向上剤及び化粧方法を提供することができる。 According to the present invention, there are provided a novel foam preparation emulsifying composition capable of forming good foam without using a surfactant, a foam agent, a method for improving foam-forming ability, a foam-forming ability improving agent, and a cosmetic method. Can be provided.
以下、本発明の実施形態について説明するが、本発明はこれに限定されない。 Hereinafter, although embodiment of this invention is described, this invention is not limited to this.
<乳化組成物>
本発明の乳化組成物は、油相、水相、自発的に閉鎖小胞体を形成する両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマーの粒子、及び増粘剤を含むフォーム剤作製用乳化組成物(以下、本明細書において、「乳化組成物」と呼称する場合がある。)である。該乳化組成物を原液として作製したフォーム剤においては、界面活性剤を用いずとも良好な泡を形成することができる。なお、「泡形成力の向上」とは、泡のキメ細かさ、泡の保持時間、泡の保持力等が向上することを意味する。
<Emulsified composition>
The emulsified composition of the present invention comprises an oil phase, an aqueous phase, particles of a polycondensation polymer having closed vesicles or hydroxyl groups formed by amphiphiles that spontaneously form closed vesicles, and a thickener. It is an emulsified composition for producing a foam agent (hereinafter sometimes referred to as “emulsified composition” in the present specification). In a foam prepared using the emulsion composition as a stock solution, good foam can be formed without using a surfactant. “Improving foam-forming ability” means that the fineness of foam, foam retention time, foam retention, and the like are improved.
本発明の乳化組成物は、自発的に閉鎖小胞体を形成する両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマーの粒子を用いた、いわゆる三相乳化法による乳化組成物である。上記のとおり、三相乳化法による乳化組成物はフォーム剤として使用するには不十分であった。三相乳化法においては、自発的に閉鎖小胞体を形成する両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマーの粒子が、油−水の界面に介在して、ファンデルワールス力により油相に付着することで乳化を可能とするものでる。三相乳化は、親水基と疎水基により界面張力を下げる界面活性剤による乳化となる異なるものである。本発明者らは、三相乳化法による乳化組成物に増粘剤を加えることで、フォーム剤としての使用においては不十分であった三相乳化法による乳化組成物においても、良好な泡を形成できることを見出した。よって、界面活性剤による乳化組成物と比較して、化粧品用として利用した場合、ベトツキ、刺激等を抑えることができ、また、洗浄用品として利用した場合、洗浄面に界面活性剤が残りにくいため、白濁を抑制することができる。 The emulsified composition of the present invention is an emulsified composition by a so-called three-phase emulsification method using closed vesicles formed of amphiphiles that spontaneously form closed vesicles or polycondensation polymer particles having a hydroxyl group. It is. As described above, the emulsion composition by the three-phase emulsification method is insufficient for use as a foaming agent. In the three-phase emulsification method, particles of a closed vesicle or a polycondensation polymer having a hydroxyl group formed by an amphiphile that spontaneously forms a closed vesicle are interposed at an oil-water interface, and the van der It can emulsify by adhering to the oil phase by the Waals force. Three-phase emulsification is different from emulsification with a surfactant that lowers the interfacial tension by hydrophilic groups and hydrophobic groups. The present inventors added a thickener to the emulsion composition by the three-phase emulsification method, so that even in the emulsion composition by the three-phase emulsification method, which was insufficient for use as a foaming agent, good foam was obtained. It was found that it can be formed. Therefore, compared to the emulsion composition with a surfactant, when used as a cosmetic, it can suppress stickiness, irritation, etc., and when used as a cleaning product, it is difficult for the surfactant to remain on the cleaning surface. , White turbidity can be suppressed.
本発明の乳化組成物が、増粘剤を含むことで良好な泡を形成することができるのは、以下の理由によるものと推測される。 It is estimated that the reason why the emulsified composition of the present invention can form a good foam by including a thickener is as follows.
エアゾール泡沫の一般的な生成機構は、乳化組成物の油相に溶解している噴射剤が大気圧下に噴出されると噴射剤が気化することで気泡が生じる(エアゾール包装技術より)。隣接する気泡−気泡間は液相となっており、気泡−液相界面は界面活性剤分子が疎水基を気泡(気相)側に、親水基を液相側に向けた状態で存在している。噴射剤が気化すると乳化組成物の油相体積が急激に増加するが、界面活性剤による乳化組成物の場合は水相中に存在している界面活性剤分子が直ちに気泡−液相界面に移動することで気泡を維持することができる。一方、三相乳化の乳化組成物の場合、気泡−液相界面は三相乳化粒子が存在するが、噴射剤が気化した際の急激な乳化組成物の油相体積増加速度にその大きさのため三相乳化粒子の移動が追い付かず、気泡を維持しにくいが、本発明によると、増粘剤により、十分に気泡を維持することができることによるものと推測できる。 The general generation mechanism of the aerosol foam is that when the propellant dissolved in the oil phase of the emulsified composition is ejected under atmospheric pressure, the propellant is vaporized to generate bubbles (from the aerosol packaging technique). Adjacent bubbles-bubbles are in the liquid phase, and the bubble-liquid interface is present with surfactant molecules with the hydrophobic groups facing the bubbles (gas phase) and the hydrophilic groups facing the liquid phase. Yes. When the propellant vaporizes, the oil phase volume of the emulsified composition increases abruptly, but in the case of an emulsified composition with a surfactant, surfactant molecules present in the aqueous phase immediately move to the bubble-liquid phase interface. By doing so, bubbles can be maintained. On the other hand, in the case of an emulsified composition of three-phase emulsification, there are three-phase emulsified particles at the bubble-liquid interface, but the magnitude of the oil phase volume increase rate of the emulsified composition when the propellant vaporizes Therefore, the movement of the three-phase emulsified particles does not catch up and it is difficult to maintain the bubbles, but according to the present invention, it can be assumed that the bubbles can be sufficiently maintained by the thickener.
本発明の乳化組成物の形態は、特に限定されず、O/W型のエマルション構造であってもよく、W/O型のエマルション構造であってもよい。特に、フォーム剤の泡の形成力が優れることから、O/W型のエマルション構造であることが好ましい。 The form of the emulsion composition of the present invention is not particularly limited, and may be an O / W type emulsion structure or a W / O type emulsion structure. In particular, an O / W type emulsion structure is preferable because foam forming power of the foam agent is excellent.
(増粘剤)
本発明における増粘剤は、上記で述べたとおり、本発明の乳化組成物において、泡形成力を向上することができる。本発明における増粘剤の種類は、フォーム剤の泡形成能力を向上させることができるものであり、具体的には、多糖類、タンパク質(乳由来タンパク質、卵由来タンパク質、小麦タンパク質、大豆由来タンパク質、ゼラチン等)、合成高分子(ビニル系、ビニリデン系、ポリアクリル系、ポリアミド系、ポリエーテル系、ポリグリコール系、ポリビニルアルコール系、ポリアルキレンオキサイド系等、及びこれらの組合せ)等が挙げられる。これらのうち、特にフォーム剤の泡の形成力が優れることから、多糖類を用いることが好ましい。これら増粘剤は、1種単独で用いてもよく、2種類以上を併用してもよい。ただし、アレルギーを防止することを目的とした場合、アレルゲンとなる増粘剤(例えば、タンパク質)を含まないことが好ましい。
(Thickener)
As described above, the thickener in the present invention can improve the foam forming power in the emulsion composition of the present invention. The type of thickener in the present invention is capable of improving the foam-forming ability of the foam agent. Specifically, polysaccharides, proteins (milk-derived protein, egg-derived protein, wheat protein, soybean-derived protein) , Gelatin, etc.), synthetic polymers (vinyl, vinylidene, polyacryl, polyamide, polyether, polyglycol, polyvinyl alcohol, polyalkylene oxide, and combinations thereof). Among these, it is preferable to use a polysaccharide because the foam-forming ability of the foam agent is particularly excellent. These thickeners may be used alone or in combination of two or more. However, for the purpose of preventing allergies, it is preferable not to include a thickener (eg, protein) that becomes an allergen.
多糖類の種類は、例えば、デンプン、デンプン誘導体、デキストリン、アルギン酸類、寒天、グァーガム、ローカストビーンガム、タラガム、フェヌグリークガム、タマリンドガム、グルコマンナン、ペクチン、キサンタンガム、ジェランガム、κカラギナン、ιカラギナン、λカラギナン、ファーセレラン、カシアガム、カードラン、クイーンスシード、アラビアゴム、サクシノグルカン、グリコサミノグリカン、セルロース系高分子(メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース等)等が挙げられる。多糖類は、1種単独で用いてもよく、2種以上を併用してもよい。本発明において、増粘剤として用いられる多糖類は、水素結合によりネットワーク構造を形成したものである。 Types of polysaccharides include, for example, starch, starch derivatives, dextrin, alginic acids, agar, guar gum, locust bean gum, tara gum, fenugreek gum, tamarind gum, glucomannan, pectin, xanthan gum, gellan gum, κ carrageenan, ι carrageenan, λ Carrageenan, far cerulean, cassia gum, curdlan, queen seed, gum arabic, succino glucan, glycosaminoglycan, cellulosic polymer (methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, etc.) Etc. A polysaccharide may be used individually by 1 type and may use 2 or more types together. In the present invention, the polysaccharide used as a thickener has a network structure formed by hydrogen bonding.
本発明における多糖類は、特にフォーム剤の泡の形成力が優れることから、デンプン、デンプン誘導体及びアルギン酸類からなる群から選択される1種以上を含むことが好ましい。デンプンとしては、特に限定されないが、タピオカデンプン、米デンプン、ジャガイモデンプン馬鈴薯デンプン、甘藷デンプン、小麦デンプン、サゴデンプン、トウモロコシデンプン、片栗粉、くず粉等の天然デンプンが利用可能である。これらのうち、特にフォーム剤の泡の形成力が優れることから、タピオカデンプンを用いることが好ましい。デンプン誘導体としては、特に限定されないが、例えば、アルケニルコハク酸デンプンの金属塩(オクテニルコハク酸デンプンナトリウム、オクテニルコハク酸デンプンアルミニウム等)、アルキルデンプン(メチルデンプン、エチルデンプン等)、カルボキシアルキルデンプン(カルボキシメチルデンプン、カルボキシエチルデンプン等)、ヒドロキシアルキルデンプン(ヒドロキシエチルデンプン、ヒドロキシプロピルデンプン等)、ヒドロキシアルキルリン酸の金属塩酸化デンプン(ヒドロキシプロピルリン酸ナトリウム等)、アセチルデンプン、アミノアセチルデンプン、アリルデンプン等を例示することができる。これらのうち、特にフォーム剤の泡の形成力が優れることから、アルケニルコハク酸デンプンの金属塩(特に、オクテニルコハク酸デンプンナトリウム)を用いることが好ましい。アルギン酸類としては、特に限定されないが、例えば、アルギン酸ナトリウム、アルギン酸カリウム、アルギン酸エステル(アルギン酸プロピレングリコールエステル等)等が挙げられるこれらのうち、特にフォーム剤の泡の形成力が優れることから、アルギン酸ナトリウムを用いることが好ましい。 The polysaccharide in the present invention preferably contains at least one selected from the group consisting of starch, starch derivatives, and alginic acids because foam forming ability of foaming agent is particularly excellent. Although it does not specifically limit as starch, Natural starch, such as tapioca starch, rice starch, potato starch potato starch, sweet potato starch, wheat starch, sago starch, corn starch, potato starch, waste flour, can be used. Among these, it is preferable to use tapioca starch because foam forming ability of the foam agent is particularly excellent. Examples of starch derivatives include, but are not limited to, metal salts of alkenyl succinate starch (starch sodium octenyl succinate, starch aluminum octenyl succinate, etc.), alkyl starch (methyl starch, ethyl starch, etc.), carboxyalkyl starch (carboxymethyl starch, etc.) Carboxyethyl starch, etc.), hydroxyalkyl starch (hydroxyethyl starch, hydroxypropyl starch, etc.), metal salt of hydroxyalkyl phosphate (such as sodium hydroxypropyl phosphate), acetyl starch, aminoacetyl starch, allyl starch, etc. It can be illustrated. Among these, it is preferable to use a metal salt of alkenyl succinate (particularly starch sodium octenyl succinate) because foam forming ability of foaming agent is particularly excellent. Alginic acids are not particularly limited, and examples thereof include sodium alginate, potassium alginate, alginates (such as propylene glycol alginate), and the like. Is preferably used.
本発明における多糖類は、水溶液の粘度が高い方が、フォーム剤の泡の形成力が優れることから、上記のうち、増粘多糖類(例えば、デンプン、デンプン誘導体、アルギン酸類、寒天、グァーガム、ローカストビーンガム、タラガム、フェヌグリークガム、タマリンドガム、グルコマンナン、キサンタンガム、ジェランガム、アラビアゴム等)を用いることが好ましい。同様の観点で、多糖類等の増粘剤は、1質量%水溶液の20℃における粘度が、100mPa・s以上であることが好ましく、1質量%水溶液の20℃における粘度が、500mPa・s以上であることがより好ましく、1質量%水溶液の20℃における粘度が、1000mPa・s以上であることがさらに好ましい。また、増粘剤の1質量%水溶液の20℃における粘度の上限は、特に限定されないが、粘度が高すぎると、組成物の粘性が高くなりすぎ、フォーム剤の使用感が減少する。また、粘度が高すぎると、噴射剤の気化が抑制され、エアゾール缶から噴射された後に少し遅れて発泡する現象(遅発泡)や熱や手指等で圧力を加えた時に気化が促進されパチパチと音をたてて発泡する現象(クラッキング)が生じ、フォーム剤としての使用に適さない。このことから、増粘剤の1質量%水溶液の20℃における粘度が、100000mPa・s以下であることが好ましく、80000mPa・s以下であることがより好ましく、60000mPa・s以下であることがさらに好ましい。20℃における粘度は、B型粘度計により測定する。 Since the polysaccharide in the present invention has a higher viscosity of the aqueous solution, the foam forming ability of the foaming agent is superior. Among the above, thickening polysaccharides (for example, starch, starch derivatives, alginic acids, agar, guar gum, Locust bean gum, tara gum, fenugreek gum, tamarind gum, glucomannan, xanthan gum, gellan gum, gum arabic, etc.) are preferably used. From the same viewpoint, the thickener such as polysaccharides preferably has a viscosity of 1% by weight aqueous solution at 20 ° C. of preferably 100 mPa · s or more, and the viscosity of 1% by weight aqueous solution at 20 ° C. of 500 mPa · s or more. The viscosity at 20 ° C. of the 1% by mass aqueous solution is more preferably 1000 mPa · s or more. Moreover, the upper limit of the viscosity at 20 ° C. of the 1% by weight aqueous solution of the thickener is not particularly limited. However, when the viscosity is too high, the viscosity of the composition becomes too high and the feeling of use of the foaming agent decreases. If the viscosity is too high, vaporization of the propellant is suppressed, and after being sprayed from an aerosol can, foaming is delayed a little (slow foaming) and vaporization is accelerated when pressure is applied with heat, fingers, etc. The phenomenon of foaming with sound (cracking) occurs, and it is not suitable for use as a foaming agent. From this, the viscosity at 20 ° C. of the 1% by weight aqueous solution of the thickener is preferably 100000 mPa · s or less, more preferably 80000 mPa · s or less, and further preferably 60000 mPa · s or less. . The viscosity at 20 ° C. is measured with a B-type viscometer.
本発明における多糖類の重量平均分子量としては、例えば、500〜1,000,000であってもよい。なお、重量平均分子量は、サイズ排除クロマトグラフィーにより測定する。 The weight average molecular weight of the polysaccharide in the present invention may be, for example, 500 to 1,000,000. The weight average molecular weight is measured by size exclusion chromatography.
本発明における増粘剤の含有量は、特に限定されず、例えば、組成物全体の質量に対して、0.01〜3.0質量%であってもよいが、量が大きい方が、フォーム剤の泡の形成力が優れることから、0.10質量%以上であることが好ましく、0.30質量%以上であることがより好ましく、0.50質量%以上であることがさらに好ましい。他方、増粘剤の含有量が大きすぎると、粘性が高くなりすぎ、フォーム剤の使用感が減少する。このことから、本発明における増粘剤の含有量は、2質量%以下であることが好ましく、1.5質量%以下であることがより好ましく、1質量%以下であることがさらに好ましい。 The content of the thickener in the present invention is not particularly limited, and may be, for example, 0.01 to 3.0% by mass relative to the mass of the entire composition. Since the foam forming power of the agent is excellent, it is preferably 0.10% by mass or more, more preferably 0.30% by mass or more, and further preferably 0.50% by mass or more. On the other hand, when the content of the thickener is too large, the viscosity becomes too high and the feeling of use of the foaming agent is reduced. From this, the content of the thickener in the present invention is preferably 2% by mass or less, more preferably 1.5% by mass or less, and further preferably 1% by mass or less.
(油相)
本発明における油相に含まれる油は、特に限定されないが、例えば、エステル油、炭化水素油、シリコーン油、油脂類(植物油、動物油、魚油等)、高級アルコール、高級脂肪酸、ステロール等が挙げられる。油は、1種単独で使用してもよく、2種以上を併用してもよい。これらのうち、フォーム剤の泡の形成力が優れることから、エステル油、炭化水素油、シリコーン油及び植物油からなる群から選択される1種以上の油を用いることが好ましい。
(Oil phase)
The oil contained in the oil phase in the present invention is not particularly limited, and examples thereof include ester oil, hydrocarbon oil, silicone oil, fats and oils (vegetable oil, animal oil, fish oil, etc.), higher alcohol, higher fatty acid, sterol and the like. . Oil may be used individually by 1 type and may use 2 or more types together. Among these, it is preferable to use one or more kinds of oils selected from the group consisting of ester oils, hydrocarbon oils, silicone oils, and vegetable oils because foam forming ability of the foaming agent is excellent.
エステル油としては、特に限定されないが、メトキシケイヒ酸エチルヘキシル、エチルヘキサン酸セチル、リンゴ酸ジイソステアリル、ミリスチン酸イソプロピル、パルミチン酸エチルヘキシル、パルミチン酸オクチル、イソパルミチン酸オクチル、イソノナン酸イソノニル、イソノナン酸イソトリデシル、ラウリル酸メチルヘプチル、ラウリン酸ヘキシル、トリ(カプリル酸/カプリン酸)グリセリル、トリエチルヘキサノイン、ジカプリン酸ネオペンチルリコール、オクタン酸セチル、ステアリン酸イソセチル、イソステアリン酸イソプロピル、オレイン酸イソデシル、トリ2−エチルヘキサン酸グリセリル、テトラ2−エチルヘキサン酸ペンタエリスリット、コハク酸2−エチルヘキシル、セバシン酸ジエチル等が挙げられる。これらのうち、フォーム剤の泡の形成力が優れることから、メトキシケイヒ酸エチルヘキシル、エチルヘキサン酸セチルを用いることが好ましい。 Examples of ester oils include, but are not limited to, ethyl hexyl methoxycinnamate, cetyl ethyl hexanoate, diisostearyl malate, isopropyl myristate, ethyl hexyl palmitate, octyl palmitate, octyl isopalmitate, isononyl isononanoate, isotridecyl isononanoate , Methyl heptyl laurate, hexyl laurate, glyceryl tri (caprylate / caprate), triethylhexanoin, neopentyl recall dicaprate, cetyl octoate, isocetyl stearate, isopropyl isostearate, isodecyl oleate, tri-2-ethyl Examples include glyceryl hexanoate, pentaerythritol tetra-2-ethylhexanoate, 2-ethylhexyl succinate, diethyl sebacate and the like. Among these, it is preferable to use ethylhexyl methoxycinnamate and cetyl ethylhexanoate because the foaming ability of the foaming agent is excellent.
炭化水素油としては、特に限定されないが、流動パラフィン、スクワラン、スクワレン、セレシン、パラフィン、ワセリン、流動イソパラフィン、マイクロクリスタリンワックス、ポリブテン、オレフィンオリゴマー等が挙げられる。これらのうち、フォーム剤の泡の形成力が優れることから、スクワランを用いることが好ましい。これらは単独で使用してもよく、2種以上を併用してもよい。 The hydrocarbon oil is not particularly limited, and examples thereof include liquid paraffin, squalane, squalene, ceresin, paraffin, petroleum jelly, liquid isoparaffin, microcrystalline wax, polybutene, and olefin oligomer. Of these, squalane is preferably used because of its excellent foam forming ability. These may be used alone or in combination of two or more.
シリコーン油としては、特に限定されないが、ジメチルシリコーン(例えばメチルポリシロキサン、オクタメチルトリシロキサン、デカメチルテトラシロキサン、高重合メチルポリシロキサン等)、メチルフェニルシリコーン、環状ジメチルシリコーン(例えばオクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、メチルシクロポリシロキサン、シクロペンタシロキサン等)、メチルハイドロジェンシリコーン、アルコール変性シリコーン(例えばステアロキシメチルポリシロキサン、セトキシメチルポリシロキサン等)、アルキル変性シリコーン、アミノ変性シリコーン等が挙げられる。これらのうち、フォーム剤の泡の形成力が優れることから、環状ジメチルシリコーンが好ましく、特にシクロペンタシロキサンを用いることが好ましい。これらは単独で使用してもよく、2種以上を併用してもよい。 The silicone oil is not particularly limited, but dimethyl silicone (for example, methylpolysiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, highly polymerized methylpolysiloxane, etc.), methylphenylsilicone, cyclic dimethylsilicone (for example, octamethylcyclotetrasiloxane). , Decamethylcyclopentasiloxane, methylcyclopolysiloxane, cyclopentasiloxane, etc.), methyl hydrogen silicone, alcohol-modified silicone (eg stearoxymethyl polysiloxane, cetoxymethyl polysiloxane, etc.), alkyl-modified silicone, amino-modified silicone, etc. Is mentioned. Of these, cyclic dimethylsilicone is preferred, and cyclopentasiloxane is particularly preferred because of its excellent foam forming ability. These may be used alone or in combination of two or more.
油脂類としては、植物油、動物油等が挙げられる。植物油としては、コメヌカ油、オリーブ油、ホホバ油、アーモンド油、ツバキ油、トウモロコシ油、ミンク油、アボガド油、サザンカ油、ヒマシ油、サフラワー油、ヒマワリ油、ナタネ油、ゴマ油、大豆油、パーシック油、アサ種子油、アマニ油、落花生油、カカオ脂、ブドウ種子油、綿実油、ヤシ油、パーム油、ココナッツ油、ピスタチオ種子油、ヘーゼルナッツ油、マカデミアナッツ油、ローズヒップ油等が挙げられる。これらのうち、フォーム剤の泡の形成力が優れることから、コメヌカ油、オリーブ油、ホホバ油、アーモンド油等を用いることが好ましい。動物油としては、牛脂、豚脂、乳脂、羊油、馬油、ミンク油、エミュウ―油、硬化油、卵黄脂肪油等が挙げられる。これらは単独で使用してもよく、2種以上を併用してもよい。 Examples of oils and fats include vegetable oils and animal oils. Vegetable oils include rice bran oil, olive oil, jojoba oil, almond oil, camellia oil, corn oil, mink oil, avocado oil, sasanqua oil, castor oil, saflower oil, sunflower oil, rapeseed oil, sesame oil, soybean oil, and permanent oil. Asa seed oil, flaxseed oil, peanut oil, cacao butter, grape seed oil, cottonseed oil, palm oil, palm oil, coconut oil, pistachio seed oil, hazelnut oil, macadamia nut oil, rosehip oil and the like. Among these, it is preferable to use rice bran oil, olive oil, jojoba oil, almond oil or the like because foam forming ability of the foaming agent is excellent. Examples of animal oils include beef tallow, lard, milk fat, sheep oil, horse oil, mink oil, emyu-oil, hydrogenated oil, egg yolk fat oil and the like. These may be used alone or in combination of two or more.
高級アルコールは、特に限定されないが、例えば、イソステアリルアルコール、オクチルドデカノール、オレイルアルコール、ラウリルアルコール、ミリスチルアルコール、セタノール、ステアリルアルコール、ベヘニルアルコール等が挙げられる。これらは単独で使用してもよく、2種以上を併用してもよい。 The higher alcohol is not particularly limited, and examples thereof include isostearyl alcohol, octyldodecanol, oleyl alcohol, lauryl alcohol, myristyl alcohol, cetanol, stearyl alcohol, and behenyl alcohol. These may be used alone or in combination of two or more.
高級脂肪酸は、特に限定されないが、例えば、イソステアリン酸、オレイン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ソルビン酸、リノール酸等が挙げられる。これらは単独で使用してもよく、2種以上を併用してもよい。 The higher fatty acid is not particularly limited, and examples thereof include isostearic acid, oleic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, sorbic acid, and linoleic acid. These may be used alone or in combination of two or more.
ステロールは、特に限定されないが、コレステロール、フィトステロール等が挙げられる。これらは単独で使用してもよく、2種以上を併用してもよい。 The sterol is not particularly limited, and examples thereof include cholesterol and phytosterol. These may be used alone or in combination of two or more.
また、本発明における油相に含まれる油は、紫外線吸収剤として用いられる油を用いてもよい。紫外線吸収剤として用いられる油としては、2−[4−(ジエチルアミノ)−2−ヒドロキシベンゾイル]安息香酸ヘキシルエステル、パラアミノ安息香酸、パラアミノ安息香酸エチル、パラアミノ安息香酸グリセリル、パラジメチルアミノ安息香酸アミル、パラジメチルアミノ安息香酸2−エチルヘキシル、4−[N,N−ジ(2−ヒドロキシプロピル)アミノ]安息香酸エチル、サリチル酸エチレングリコール、サリチル酸2−エチルヘキシル、サリチル酸ホモメンチル、パラメトキシケイ皮酸2−エトキシエチル、パラメトキシケイ皮酸2−エチルヘキシル、ジパラメトキシケイ皮酸モノ2−エチルヘキサン酸グリセリル、ジヒドロキシジメトキシベンゾフェノン、ジヒドロキシジメトキシジベンゾフェノンジスルホン酸ナトリウム、ジヒドロキシベンゾフェノン、テトラヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン、ヒドロキシメトキシベンゾフェノンスルホン酸、ヒドロキシメトキシベンゾフェノンスルホン酸ナトリウム、フェルラ酸、アントラニル酸メンチル、ジメチコジエチルベンザルマロネート、テレフタリリデンジカンフルスルホン酸、2,4,6−トリス[4−(2−エチルヘキシルオキシカルボニル)アニリノ]−1,3,5−トリアジン、4−tert−ブチル−4’−メトキシ−ジベンゾイルメタン、2,2−メチレンビス(6−(2Hベンゾトリアゾール−2−イル)−4−(1,1,3,3−テトラメチルブチル)フェノール)等)が挙げられる。 Moreover, you may use the oil used as a ultraviolet absorber as the oil contained in the oil phase in this invention. Examples of oils used as ultraviolet absorbers include 2- [4- (diethylamino) -2-hydroxybenzoyl] benzoic acid hexyl ester, paraaminobenzoic acid, ethyl paraaminobenzoate, glyceryl paraaminobenzoate, amyl paradimethylaminobenzoate, 2-Ethylhexyl paradimethylaminobenzoate, ethyl 4- [N, N-di (2-hydroxypropyl) amino] benzoate, ethylene glycol salicylate, 2-ethylhexyl salicylate, homomenthyl salicylate, 2-ethoxyethyl paramethoxycinnamate , 2-methoxyhexyl paramethoxycinnamate, glyceryl mono-2-ethylhexanoate diparamethoxycinnamate, dihydroxydimethoxybenzophenone, sodium dihydroxydimethoxydibenzophenone disulfonate, Hydroxybenzophenone, tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, hydroxymethoxybenzophenone sulfonic acid, sodium hydroxymethoxybenzophenone sulfonate, ferulic acid, menthyl anthranilate, dimethicodiethylbenzalmalonate, terephthalylidene dicamphorsulfone Acid, 2,4,6-tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine, 4-tert-butyl-4'-methoxy-dibenzoylmethane, 2,2-methylenebis (6- (2Hbenzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol) and the like.
本発明における乳化組成物全体の質量に対する油の含有量は、特に限定されず、乳化組成物の形態や目的に応じて、適宜選択することができる。ただし、油の量が過剰であると、フォーム剤が泡を形成しにくくなる傾向があるが、本発明における乳化組成物によると、油の量が多く入っていても、泡を形成することができ、さらに、人体又は動物に適用した場合に油の量が多く入っていても、べとつきにくい。この観点において、1.0質量%以上であることが好ましく、5.0質量%以上であることがより好ましく、10.0質量%以上であることがさらに好ましく、20質量%以上であることがより一層好ましく、28質量%以上であることが最も好ましい。ただし、多すぎると、泡を形成しにくくなることから、例えば、90質量%以下であることが好ましく、60質量%以下であることがより好ましく、50質量%以下であることがさらに好ましく、40質量%以下であることがより一層好ましく、35質量%以下であることが最も好ましい。特に、本発明の乳化組成物がO/W型のエマルション構造である場合は、油の含有量が上記範囲内にあることが好ましい。 The oil content relative to the mass of the entire emulsion composition in the present invention is not particularly limited, and can be appropriately selected according to the form and purpose of the emulsion composition. However, if the amount of oil is excessive, the foam agent tends to hardly form foam, but according to the emulsion composition of the present invention, foam may be formed even if the amount of oil is large. Furthermore, even when the amount of oil is large when applied to the human body or animal, it is difficult to stick. In this respect, it is preferably 1.0% by mass or more, more preferably 5.0% by mass or more, further preferably 10.0% by mass or more, and 20% by mass or more. Even more preferred is 28% by weight or more. However, since it is difficult to form bubbles when it is too much, for example, it is preferably 90% by mass or less, more preferably 60% by mass or less, further preferably 50% by mass or less, It is still more preferable that it is mass% or less, and it is most preferable that it is 35 mass% or less. In particular, when the emulsion composition of the present invention has an O / W type emulsion structure, the oil content is preferably within the above range.
(水相)
本発明における閉鎖小胞体又は重縮合ポリマーの粒子は、乳化性能に極めて優れる。このため、乳化組成物における水の量は、0.1〜95質量%の範囲から幅広く選択することができ、乳化組成物の形態や油相の量に応じて適宜設定することができる。例えば、10〜90質量%であることが好ましく、30質〜80量%であることがより好ましく、50〜70質量%であることがさらに好ましい。特に、本発明の乳化組成物がO/W型のエマルション構造である場合は、水の含有量が上記範囲内にあることが好ましい。
(Water phase)
The closed vesicle or polycondensation polymer particles in the present invention are extremely excellent in emulsification performance. For this reason, the amount of water in the emulsified composition can be widely selected from the range of 0.1 to 95% by mass, and can be appropriately set according to the form of the emulsified composition and the amount of the oil phase. For example, it is preferably 10 to 90% by mass, more preferably 30 to 80% by mass, and even more preferably 50 to 70% by mass. In particular, when the emulsion composition of the present invention has an O / W type emulsion structure, the water content is preferably within the above range.
(閉鎖小胞体又は重縮合ポリマー粒子)
本発明における閉鎖小胞体は、自発的に閉鎖小胞体を形成する両親媒性物質により形成される。閉鎖小胞体を形成する両親媒性物質としては、下記の一般式1で表されるポリオキシエチレン硬化ひまし油の誘導体もしくは一般式2で表されるようなジアルキルアンモニウム誘導体、トリアルキルアンモニウム誘導体、テトラアルキルアンモニウム誘導体、ジアルケニルアンモニウム誘導体、トリアルケニルアンモニウム誘導体、又はテトラアルケニルアンモニウム誘導体のハロゲン塩の誘導体を採用するとよい。
(Closed endoplasmic reticulum or polycondensation polymer particles)
The closed endoplasmic reticulum in the present invention is formed by an amphipathic substance that spontaneously forms a closed endoplasmic reticulum. Examples of amphiphilic substances that form closed endoplasmic reticulum include polyoxyethylene hydrogenated castor oil derivatives represented by the following general formula 1 or dialkylammonium derivatives, trialkylammonium derivatives, tetraalkyls represented by the general formula 2 A halogen salt derivative of an ammonium derivative, dialkenyl ammonium derivative, trialkenyl ammonium derivative, or tetraalkenyl ammonium derivative may be employed.
一般式1
式中、エチレンオキシドの平均付加モル数であるEは、3〜100である。Eが過大になると、両親媒性物質を溶解する良溶媒の種類が制限されるため、親水性ナノ粒子の製造の自由度が狭まる。このことから、Eの上限は好ましくは50であり、より好ましくは40である。Eの下限は、フォーム剤の泡の形成力が向上することから、好ましくは5以上であり、より好ましくは10以上であり、さらに好ましくは20以上であり、最も好ましくは30以上である。 In the formula, E, which is the average added mole number of ethylene oxide, is 3 to 100. If E is excessive, the type of good solvent that dissolves the amphiphilic substance is limited, and thus the degree of freedom in producing hydrophilic nanoparticles is narrowed. From this, the upper limit of E is preferably 50, more preferably 40. The lower limit of E is preferably 5 or more, more preferably 10 or more, still more preferably 20 or more, and most preferably 30 or more because foam forming ability of the foaming agent is improved.
一般式2
式中、R1及びR2は、各々独立して炭素数8〜22のアルキル基又はアルケニル基であり、R3及びR4は、各々独立して水素又は炭素数1〜4のアルキル基であり、XはF、Cl、Br、I又はCH3COOである。 In the formula, R 1 and R 2 are each independently an alkyl group or alkenyl group having 8 to 22 carbon atoms, R 3 and R 4 are each independently hydrogen or an alkyl group having 1 to 4 carbon atoms, and X is F, Cl, Br, I or CH 3 COO.
あるいは、リン脂質やリン脂質誘導体等を採用してもよい。リン脂質としては、下記の一般式3で示される構成のうち、炭素鎖長12のDLPC(1,2−Dilauroyl−sn−glycero−3−phospho−rac−1−choline)、炭素鎖長14のDMPC(1,2−Dimyristoyl−sn−glycero−3−phospho−rac−1−choline)、炭素鎖長16のDPPC(1,2−Dipalmitoyl−sn−glycero−3−phospho−rac−1−choline)が採用可能である。 Alternatively, phospholipids, phospholipid derivatives, and the like may be employed. As the phospholipid, among the structures represented by the following general formula 3, DLPC (1,2-Dilauroyl-sn-glycero-3-phospho-rac-1-choline) having a carbon chain length of 12, DMPC (1,2-Dimyristol-sn-glycero-3-phospho-rac-1-choline), DPPC with a carbon chain length of 16 (1,2-Dipalmitoyyl-sn-glycero-3-phospho-rac-1-choline) Can be adopted.
一般式3
また、下記の一般式4で示される構成のうち、炭素鎖長12のDLPG(1,2−Dilauroyl−sn−glycero−3−phospho−rac−1−glycerol)のNa塩又はNH4塩、炭素鎖長14のDMPG(1,2−Dimyristoyl−sn−glycero−3−phospho−rac−1−glycerol)のNa塩又はNH4塩、炭素鎖長16のDPPG(1,2−Dipalmitoyl−sn−glycero−3−phospho−rac−1−glycerol)のNa塩又はNH4塩を採用してもよい。 In addition, among the structures represented by the following general formula 4, DLPG (1,2-Diilauroyl-sn-glycero-3-phospho-rac-1-glycerol) Na salt or NH 4 salt of carbon chain length 12 and carbon DMPG chain length 14 (1,2-dimyristoyl-sn- glycero-3-phospho-rac-1-glycerol) Na salt or NH 4 salt, DPPG (1,2-Dipalmitoyl-sn -glycero carbon chain length 16 Na salt or NH 4 salt of -3-phospho-rac-1-glycerol) may be employed.
一般式4
また、リン脂質、リン脂質誘導体としては、レシチン(天然レシチン、水添レシチン等)を用いることができる。 As phospholipids and phospholipid derivatives, lecithin (natural lecithin, hydrogenated lecithin, etc.) can be used.
両親媒性物質としては、フォーム剤の泡形成力が向上することから、ポリオキシエチレン硬化ひまし油の誘導体(日光ケミカルズ株式会社社製の「HCO−10」、「HCO−30」、「HCO−50」、「HCO−100」等)、ジラウロイルグルタミン酸リシンNa、レシチンを用いることが好ましい。 As the amphiphilic substance, foam forming ability of the foaming agent is improved, so that derivatives of polyoxyethylene hydrogenated castor oil (“HCO-10”, “HCO-30”, “HCO-50” manufactured by Nikko Chemicals Co., Ltd.) are used. ”,“ HCO-100 ”, etc.), dilauroyl glutamate lysine Na, and lecithin are preferably used.
水酸基を有する重縮合ポリマーは、特に限定されず、天然高分子又は合成高分子のいずれであってもよく、用途に応じて適宜選択されてよい。ただし、安全性に優れ、一般的に安価である点で、天然高分子が好ましく、乳化機能に優れる点で以下に述べる糖ポリマーがより好ましい。なお、粒子とは、重縮合ポリマーが単粒子化したもの、又はその単粒子同士が連なったもののいずれも包含する一方、単粒子化される前の凝集体(網目構造を有する)は包含しない。上述の「多糖類」は粒子化されているものではなく、水素結合によるネットワーク構造を形成していることから、いわゆる三相乳化能を有する「重縮合ポリマーの粒子」とは、明確に異なるものである。重縮合ポリマーが粒子化されているか否かは、電子顕微鏡による観察や粒度分布計により確認することができる。水酸基を有する重縮合ポリマーは、1種のみを単独で使用してもよく、2種以上を併用してもよい。 The polycondensation polymer having a hydroxyl group is not particularly limited, and may be either a natural polymer or a synthetic polymer, and may be appropriately selected depending on the application. However, natural polymers are preferable from the viewpoint of safety and generally inexpensive, and sugar polymers described below are more preferable from the viewpoint of excellent emulsifying function. In addition, while the particle | grain includes both the thing which the polycondensation polymer was made into the single particle, or the thing with which the single particle connected, on the other hand, the aggregate (it has a network structure) before making into a single particle is not included. The above-mentioned “polysaccharides” are not particles, but form a network structure by hydrogen bonding, so they are clearly different from “polycondensation polymer particles” that have a so-called three-phase emulsifying ability. It is. Whether or not the polycondensation polymer is made into particles can be confirmed by observation with an electron microscope or a particle size distribution meter. The polycondensation polymer having a hydroxyl group may be used alone or in combination of two or more.
糖ポリマーは、セルロース、デンプン等のグルコシド構造を有するポリマーである。例えば、リボース、キシロース、ラムノース、フコース、グルコース、マンノース、グルクロン酸、グルコン酸等の単糖類の中からいくつかの糖を構成要素として微生物が産生するもの、キサンタンガム、アラビアゴム、グァーガム、カラヤガム、カラギーナン、ペクチン、フコイダン、クインシードガム、トラントガム、ローカストビーンガム、ガラクトマンナン、カードラン、ジェランガム、フコゲル、カゼイン、ゼラチン、デンプン、コラーゲン、シロキクラゲ多糖類等の天然高分子、メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、カルボキシメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、ステアロキシヒドロキシプロピルメチルセルロース、カルボキシメチルセルロースナトリウム、アルギン酸プロピレングリコールエステル、セルロース結晶体、デンプン・アクリル酸ナトリウムグラフト重合体、疎水化ヒドロキシプロピルメチルセルロース等の半合成高分子等が挙げられる。また、糖ポリマーの他に、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸塩、ポリエチレンオキシド等の合成高分子等を用いることができる。これらは、1種のみを単独で使用してもよく、2種以上を併用してもよい。 The sugar polymer is a polymer having a glucoside structure such as cellulose and starch. For example, those produced by microorganisms with some sugars among monosaccharides such as ribose, xylose, rhamnose, fucose, glucose, mannose, glucuronic acid, gluconic acid, xanthan gum, gum arabic, guar gum, caraya gum, carrageenan , Pectin, fucoidan, quinseed gum, tranto gum, locust bean gum, galactomannan, curdlan, gellan gum, fucogel, casein, gelatin, starch, collagen, white jellyfish polysaccharide, natural polymers, methylcellulose, ethylcellulose, methylhydroxypropylcellulose , Carboxymethylcellulose, hydroxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, Allo carboxymethyl hydroxypropyl methyl cellulose, sodium carboxymethyl cellulose, propylene glycol alginate, cellulose crystals, starch-acrylic acid sodium graft polymers include semi-synthetic polymers such as hydrophobic hydroxypropyl methylcellulose. In addition to the sugar polymer, synthetic polymers such as polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, polyacrylate, and polyethylene oxide can be used. These may be used alone or in combination of two or more.
糖ポリマーは、ヒドロキシエチルセルロース、ステアロキシヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース、カルボキシメチルセルロース、グァーガム、又はこれらの塩を用いることが好ましく、特に、ヒドロキシエチルセルロースを用いることが、フォーム剤の泡形成力を向上できることから好ましい。 The sugar polymer is preferably hydroxyethylcellulose, stearoxyhydroxypropylmethylcellulose, carboxymethylcellulose, carboxymethylcellulose, guar gum, or a salt thereof. In particular, the use of hydroxyethylcellulose can improve the foam-forming ability of the foam agent. preferable.
本発明における閉鎖小胞体又は重縮合ポリマー粒子は、例えば、平均粒径8nm〜2000nm程度であってもよいが、粒径が小さい方が、フォーム剤の泡保持力が向上する。このことから、平均粒径は8nm以上800nm以下であることが好ましく、8nm以上500nm以下であることがさらに好ましい。これらの調製方法は、特許第3855203号等に開示されるとおり、三相乳化能を有する粒子の調製方法として従来公知であるため、省略する。なお、三相乳化可能な粒子か否かは、乳化に用いる親水性ナノ粒子分散液について、光散乱測定を行い、平均粒子径が、例えば、8〜400nmになっていることで判断できる。さらに調製したエマルションについて、原子間顕微鏡(AFM)観察を行い、乳化剤粒子が、油滴表面に付着していることを確認することで、判断することができる。 The closed endoplasmic reticulum or polycondensation polymer particles in the present invention may have an average particle size of about 8 nm to 2000 nm, for example, but the smaller the particle size, the better the foam retention of the foam agent. From this, the average particle size is preferably 8 nm or more and 800 nm or less, and more preferably 8 nm or more and 500 nm or less. Since these preparation methods are conventionally known as methods for preparing particles having three-phase emulsification ability as disclosed in Japanese Patent No. 3855203, etc., the description thereof is omitted. Whether or not the particles can be emulsified in three phases can be determined by performing light scattering measurement on the hydrophilic nanoparticle dispersion used for emulsification and having an average particle diameter of, for example, 8 to 400 nm. Furthermore, about the prepared emulsion, it can judge by performing atomic microscope (AFM) observation and confirming that the emulsifier particle has adhered to the oil-droplet surface.
閉鎖小胞体又は重縮合ポリマー粒子の量は、油相の量に応じて適宜設定されてよく、特に限定されないが、合計で0.0001〜5質量%であってよい。これにより、フォーム剤の泡形成力が向上する。従来の界面活性剤と異なり、閉鎖小胞体又は重縮合ポリマー粒子は優れた乳化特性を有するため、5質量%以下(具体的には、4質量%以下、3質量%以下、2質量%以下、1.0質量%以下、0.75質量%以下)という少量でも、乳化状態を維持することができる。なお、上記量は、いずれも固形分含量である。また、閉鎖小胞体又は重縮合ポリマー粒子の量が多い方が、より多くの含んでも、フォーム剤が泡を形成できることから、乳化組成物全体の質量に対して0.10質量%以上であることが好ましく、0.30質量%以上であることがより好ましく、0.50質量%以上であることがさらに好ましく、0.70質量%以上であることが最も好ましい。 The amount of the closed vesicle or the polycondensation polymer particles may be appropriately set according to the amount of the oil phase, and is not particularly limited, but may be 0.0001 to 5% by mass in total. Thereby, the foam formation power of a foaming agent improves. Unlike conventional surfactants, closed endoplasmic reticulum or polycondensation polymer particles have excellent emulsifying properties, and therefore 5% by mass or less (specifically, 4% by mass or less, 3% by mass or less, 2% by mass or less, The emulsified state can be maintained even with a small amount of 1.0% by mass or less and 0.75% by mass or less. In addition, all the said amounts are solid content. Moreover, since the foam agent can form foam even if the amount of the closed vesicles or polycondensation polymer particles is larger, the foaming agent can form a foam, so that the amount is 0.10% by mass or more based on the total mass of the emulsified composition. Is preferably 0.30% by mass or more, more preferably 0.50% by mass or more, and most preferably 0.70% by mass or more.
本発明における乳化組成物の内相の平均粒径は、特に限定されず、例えば、0.001μm以上であってもよいが、本発明における乳化組成物は、三相乳化によるものであるため、界面活性剤を利用した従来の乳化と比較すると、平均粒径の大きさを幅広い範囲にすることが可能である。例えば、本発明における乳化組成物がO/W型エマルション構造を有する場合、内相である油相の平均粒径は、目的や用途に応じて適宜設定してもよいが、例えば、フォーム剤の泡形成を目的として使用する場合、内相の平均粒径は、500μm以下であることが好ましく、250μm以下であることがより好ましく、100μm以下であることがさらに好ましい。なお、内相の平均粒径は、濃厚系対応粒径アナライザーFPAR−1000(大塚電子(株)製)により、測定する。 The average particle size of the inner phase of the emulsion composition in the present invention is not particularly limited, and may be, for example, 0.001 μm or more, but the emulsion composition in the present invention is based on three-phase emulsification, Compared with conventional emulsification using a surfactant, the average particle size can be in a wide range. For example, when the emulsion composition of the present invention has an O / W emulsion structure, the average particle size of the oil phase that is the internal phase may be appropriately set according to the purpose and application. When used for the purpose of foam formation, the average particle size of the inner phase is preferably 500 μm or less, more preferably 250 μm or less, and even more preferably 100 μm or less. The average particle size of the inner phase is measured with a dense system particle size analyzer FPAR-1000 (manufactured by Otsuka Electronics Co., Ltd.).
本発明における乳化組成物は、上記以外の成分の他、香料、pH調整剤、防腐剤、着色剤、抗酸化剤、界面活性剤や他の乳化剤を併用して含んでもよく、含まなくてもよい。ただし、べとつき、刺激等を抑えるという観点においては、乳化組成物中の界面活性剤の含有量は、少ない方が好ましく、例えば、乳化組成物全体の質量に対して10質量%以下(5質量%以下、1質量%以下、0.1質量%以下、0.05質量%以下、0.01質量%以下等)であることが好ましく、乳化組成物が界面活性剤を含まない方がより好ましい。 The emulsified composition of the present invention may or may not contain a fragrance, a pH adjuster, a preservative, a colorant, an antioxidant, a surfactant and other emulsifiers in addition to the components other than those described above. Good. However, from the viewpoint of suppressing stickiness, irritation and the like, the content of the surfactant in the emulsion composition is preferably small, for example, 10% by mass or less (5% by mass with respect to the total mass of the emulsion composition). Hereinafter, it is preferably 1% by mass or less, 0.1% by mass or less, 0.05% by mass or less, 0.01% by mass or less, and the like, and more preferably the emulsion composition does not contain a surfactant.
卵白等のタンパク質を用いることで、フォーム剤における泡を形成力できることが知られているが、タンパク質を用いて人体に適用する場合、タンパク質がアレルゲンとして作用することが懸念される。しかしながら、本発明は、卵白等のタンパク質を利用せずとも、十分な泡を形成できる。この観点で、本発明の乳化組成物は、タンパク質を含まないフォーム剤作製用の乳化物として利用するのに適している。 It is known that foams in foams can be formed by using a protein such as egg white, but there is a concern that the protein may act as an allergen when applied to the human body using the protein. However, the present invention can form sufficient bubbles without using protein such as egg white. From this viewpoint, the emulsified composition of the present invention is suitable for use as an emulsion for preparing a foam containing no protein.
乳化組成物は、閉鎖小胞体又は重縮合ポリマー粒子を含む分散液と、油性成分とを混合してO/W型又はW/O型エマルションの組成物を調製し、これとは別に、増粘剤の水溶液を調製し、これらを混合することで調製することができる。水溶性の任意成分は、乳化前に添加してもよく、混合前に添加してもよく、混合後に添加してもよい。 The emulsified composition is prepared by mixing a dispersion containing closed vesicles or polycondensation polymer particles with an oil component to prepare a composition of an O / W type or W / O type emulsion. It can be prepared by preparing an aqueous solution of the agent and mixing them. The water-soluble optional component may be added before emulsification, may be added before mixing, or may be added after mixing.
<フォーム剤>
本発明におけるフォーム剤は、上述の乳化組成物からなる原液と、噴射剤とを含むものである。つまり、本発明におけるフォーム剤はエアゾールの形態で用いられる。本発明におけるフォーム剤は、上述のとおり、界面活性剤を用いずとも泡を形成することができる。
<Foaming agent>
The foam agent in the present invention includes a stock solution composed of the above-mentioned emulsion composition and a propellant. That is, the foam agent in the present invention is used in the form of an aerosol. As described above, the foam agent in the present invention can form bubbles without using a surfactant.
(噴射剤)
噴射剤としては、特に限定されないが、圧縮ガス、液化ガス又はこれらの混合ガスを用いることができる。液化ガスの方が、乳化組成物に溶けやすく、結果的に泡を形成しやすくなることから、噴射剤としては液化ガスを用いることが好ましい。
(Propellant)
Although it does not specifically limit as a propellant, Compressed gas, liquefied gas, or these mixed gas can be used. Since the liquefied gas is more easily dissolved in the emulsified composition and as a result, bubbles are easily formed, it is preferable to use the liquefied gas as the propellant.
液化ガスとしては、特に限定されないが、例えば、ブタン、プロパン、ジメチルエーテル、フロロカーボン、液化石油ガス等が挙げられる。これらは、単独で使用してもよく、2種以上を併用してもよい。 The liquefied gas is not particularly limited, and examples thereof include butane, propane, dimethyl ether, fluorocarbon, and liquefied petroleum gas. These may be used alone or in combination of two or more.
液化ガスの含有量は、特に限定されず、例えば、液化ガスと原液との合計質量に対し、0.5〜60質量%の範囲で、液化ガスの原液に対する溶解性等を考慮して適宜決定してもよい。液化ガスの量を多くすると、泡を形成する能力が向上することができることから、液化ガスの含有量は、液化ガスと原液との合計質量に対し、1.0質量%以上であることが好ましく、2.0質量%以上であることがより好ましく、3.0質量%以上であることがさらに好ましく、5.0質量%以上であること最も好ましい。 The content of the liquefied gas is not particularly limited, and is appropriately determined in consideration of the solubility of the liquefied gas in the stock solution in the range of 0.5 to 60% by mass with respect to the total mass of the liquefied gas and the stock solution. May be. When the amount of the liquefied gas is increased, the ability to form bubbles can be improved. Therefore, the content of the liquefied gas is preferably 1.0% by mass or more with respect to the total mass of the liquefied gas and the stock solution. 2.0% by mass or more, more preferably 3.0% by mass or more, and most preferably 5.0% by mass or more.
液化ガスを用いる場合の圧力は、20℃の温度における圧力が例えば、0.2〜1.0MPaのものを用いることができるが、圧力が高い方が、泡を形成する能力が向上することから、0.25MPa以上であることが好ましく、0.3MPa以上であることがより好ましい。 As the pressure when using the liquefied gas, a pressure at a temperature of 20 ° C., for example, 0.2 to 1.0 MPa can be used, but the higher the pressure, the better the ability to form bubbles. , 0.25 MPa or more, more preferably 0.3 MPa or more.
圧縮ガスとしては、特に限定されないが、例えば、N2、CO2、N2O等を使用してもよく、あるいは、空気等の複数のガスの混合物を使用することができる。これらの圧縮ガスを用いた場合、泡を形成しにくくなるが、本発明のフォーム剤は、上記のとおり泡形成力に優れることから、圧縮ガスを用いても泡を形成できる。 The compressed gas is not particularly limited, for example, may be used N 2, CO 2, N 2 O or the like, or can be a mixture of a plurality of gas such as air. When these compressed gases are used, it is difficult to form bubbles. However, since the foam agent of the present invention is excellent in foam forming ability as described above, it is possible to form bubbles even if compressed gas is used.
圧縮ガスの圧力は、特に限定されないが、例えば、高圧ガス保安法で規定されているとおり、35℃で1MPa未満、かつ、常用温度で1MPa未満(例えば、0.1〜0.91MPa)とすることができる。圧力が高い方が、泡を形成する能力が向上することから、0.3MPa以上であることが好ましく、0.5MPa以上であることがより好ましい。 Although the pressure of compressed gas is not specifically limited, For example, as prescribed | regulated by the high pressure gas safety law, it is less than 1 MPa at 35 degreeC and less than 1 MPa (for example, 0.1-0.91 MPa) at normal temperature. be able to. A higher pressure improves the ability to form bubbles, and is preferably 0.3 MPa or more, and more preferably 0.5 MPa or more.
(フォーム剤の製造方法)
本発明におけるフォーム剤の製造は、常法にしたがって行うことができる。例えば、準備した乳化組成物からなる原液を、容器に加え、これに噴射剤を充填することで行うことができる。
(Method for producing foam agent)
The foam agent in the present invention can be produced according to a conventional method. For example, it can carry out by adding the stock solution which consists of the prepared emulsion composition to a container, and filling this with a propellant.
フォーム剤を充填する容器は、特に限定されず、従来の公知のフォーム剤の容器として使用できるものを使用することができる。例えば、金属、樹脂、ガラス等の材質のものを使用することができる。また、必要に応じて、バルブ、アクチュエーター、キャップ等の、従来の公知のフォーム剤の容器に備え付けられるものを、容器に備えてもよい。 The container filled with the foam agent is not particularly limited, and a container that can be used as a container of a conventionally known foam agent can be used. For example, a material such as metal, resin, or glass can be used. Moreover, you may equip a container with what is equipped with the container of the conventional well-known foam agent, such as a valve | bulb, an actuator, and a cap as needed.
(用途)
本発明のフォーム剤の用途は、特に限定されず、例えば、人体用品(化粧品、医薬部外品、医薬品等)、動物用品(ペット用品等)、工業用製品(洗浄用品等)等に用いることができる。本発明のフォーム剤は、界面活性剤を用いずも、泡を形成でき、ベトツキや刺激を抑制できることから、人体又は動物に適用される用途(化粧品等)として用いるのが好適である。また、別の観点で、工業用の洗浄用品として利用した場合に、洗浄面に残りにくく、白濁しにくくなることから、本発明のフォーム剤は工業用の洗浄用品として用いるにも好適である。
(Use)
The use of the foam agent of the present invention is not particularly limited. For example, it is used for human body products (cosmetics, quasi-drugs, pharmaceutical products, etc.), animal products (pet products, etc.), industrial products (cleaning products, etc.), etc. Can do. Since the foam agent of the present invention can form foam without using a surfactant and can suppress stickiness and irritation, it is preferably used for applications (such as cosmetics) applied to the human body or animals. From another viewpoint, when used as an industrial cleaning product, the foam of the present invention is suitable for use as an industrial cleaning product because it hardly remains on the cleaning surface and does not easily become cloudy.
<泡形成力を向上させる方法>
本発明は、油相、水相、及び自発的に閉鎖小胞体を形成する両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマーの粒子を含むフォーム剤作製用乳化組成物中に、さらに、増粘剤を含有させることにより、泡形成力を向上させる方法を包含する。
<Method for improving foam-forming ability>
The present invention relates to an emulsified composition for foam preparation comprising an oil phase, an aqueous phase, and particles of a polycondensation polymer having a closed vesicle or a hydroxyl group formed by an amphiphile that spontaneously forms a closed vesicle. Furthermore, the method of improving a foam formation power by including a thickener is included.
フォーム剤作製用乳化組成物は、上述の本発明の乳化組成物におけるものと同様のものを用いることができる。増粘剤は、上述の本発明の乳化組成物における増粘剤と同様のものを用いることができる。 As the emulsion composition for forming a foam agent, the same one as in the above-described emulsion composition of the present invention can be used. As the thickener, those similar to the thickener in the above-described emulsion composition of the present invention can be used.
<泡形成力向上剤>
本発明は、増粘剤からなる、油相、水相、及び自発的に閉鎖小胞体を形成する両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマーの粒子を含むフォーム剤作製用乳化組成物における泡形成力向上剤を包含する。
<Foam forming power improver>
The present invention relates to a foam agent comprising particles of a polycondensation polymer having a closed endoplasmic reticulum or a hydroxyl group formed of an oil phase, an aqueous phase, and an amphiphile that spontaneously forms a closed endoplasmic reticulum, comprising a thickener. The foam-forming ability improving agent in the emulsified composition for preparation is included.
「泡形成力向上剤」とは、泡のキメ細かさ、泡の保持時間、泡の保持力等を向上させるための用途を意味する。 The “foam forming ability improver” means an application for improving the fineness of foam, the retention time of foam, the retention capacity of foam, and the like.
<化粧方法>
本発明は、上記フォーム剤を、人体又は動物に適用する工程を有する、化粧方法を包含する。本発明の化粧方法によると、フォーム剤において界面活性剤やタンパク質を用いずとも泡を形成できることから、人体又は動物に適用した場合に、ベトツキや刺激を抑えることができ、また、タンパク質によるアレルギーを回避することができる。人体又は動物に適用する場合、例えば、人体又は動物の皮膚表面や毛髪に対して付着させることで行うことができる。
<Makeup method>
This invention includes the cosmetic method which has the process of applying the said foam agent to a human body or an animal. According to the cosmetic method of the present invention, foam can be formed without using a surfactant or protein in the foam, so that when applied to the human body or animal, stickiness and irritation can be suppressed, and allergy due to protein can be prevented. It can be avoided. When applying to a human body or an animal, for example, it can be performed by attaching to the skin surface or hair of the human body or animal.
フォーム剤は、上述の本発明のフォーム剤と同様のものを用いることができる。 As the foam agent, the same foam agent as that of the present invention described above can be used.
<実施例1〜5、比較例1、2>
(フォーム剤の調製)
まず、後述する表1に示すとおりに、増粘剤として、多糖類であるオクテニルコハク酸デンプンNaの量を用いて多糖類水溶液を調製した。一方でジラウロイルグルタミン酸リシンNaの閉鎖小胞体の分散液を調製し、この分散液に、スクワラン、水を加えて攪拌し、O/W型エマルションの三相乳化組成物を調製した。多糖類水溶液と三相乳化組成物とを混合して水を添加し、実施例1〜5に係るフォーム剤の原液を調製した。他方、オクテニルコハク酸デンプンNaの多糖類水溶液を用いずに、O/W型エマルションの三相乳化組成物のみからなるフォーム剤の原液を、表1の処方となるように調製し、これを比較例1に係るフォーム剤の原液とした。また、オクテニルコハク酸デンプンNaと水のみからなるフォーム剤の原液を、表1の処方となるように調製し、これを比較例2に係るフォーム剤の原液とした。
<Examples 1-5, Comparative Examples 1 and 2>
(Preparation of foam agent)
First, as shown in Table 1 described later, an aqueous polysaccharide solution was prepared using the amount of starch octenyl succinate Na, which is a polysaccharide, as a thickener. On the other hand, a closed vesicle dispersion of dilauroylglutamate ricin Na was prepared, and squalane and water were added to this dispersion and stirred to prepare a three-phase emulsion composition of an O / W emulsion. The aqueous polysaccharide solution and the three-phase emulsion composition were mixed and water was added to prepare a stock solution of foaming agents according to Examples 1-5. On the other hand, without using an aqueous polysaccharide solution of starch octenyl succinate Na, a stock solution of a foam agent consisting only of a three-phase emulsion composition of an O / W type emulsion was prepared so as to have the formulation shown in Table 1, and this was compared with Comparative Example. A foam stock solution according to No. 1 was used. Moreover, the stock solution of the foam agent which consists only of starch octenyl succinate Na and water was prepared so that it might become the prescription of Table 1, and this was made into the stock solution of the foam agent which concerns on the comparative example 2.
調製した実施例1〜5、比較例1、2に係る原液を、耐圧ガラス瓶に収容し、次いで、原液に対して、液化ガスとして、L−0.29(ブタンとプロパンとの混合ガス、20℃における圧力:0.29MPa)を充填し、実施例1〜5、比較例1、2に係るフォーム剤を調製した。それぞれの成分の添加量は、最終的な質量比が後述する表1のとおりとなるようにした。 The prepared stock solutions according to Examples 1 to 5 and Comparative Examples 1 and 2 were accommodated in a pressure-resistant glass bottle, and then L-0.29 (mixed gas of butane and propane, 20 as a liquefied gas with respect to the stock solution) The foaming agent according to Examples 1 to 5 and Comparative Examples 1 and 2 was prepared. The amount of each component added was such that the final mass ratio was as shown in Table 1 described later.
(評価1)
実施例1〜5、比較例1、2に係るフォーム剤について、噴射剤を充填した後に、泡の形成能を目視で観察し、泡のキメ細やかさ、泡の保持時間、泡の保持力及びこれら全体を考慮してフォーム剤としての総合評価について評価を行った。
(Evaluation 1)
For the foams according to Examples 1 to 5 and Comparative Examples 1 and 2, after filling the propellant, the foam forming ability was visually observed, the fineness of the foam, the foam retention time, the foam retention power and The overall evaluation as a foam agent was evaluated in consideration of the whole.
泡のキメ細やかさは、以下のとおりの基準とした。
×:泡をあまり形成できず、キメ細やかさがなかった。
△:泡がややキメ細やかであった。
〇:泡が細やかであった。
◎:泡が非常に細やかであった。
The fineness of the foam was determined as follows.
X: Bubbles could not be formed so much and there was no fine texture.
Δ: Bubbles were slightly fine.
◯: Bubbles were fine.
A: Bubbles were very fine.
泡の保持時間は、以下のとおりの基準とした。
×:泡の形成時間が非常に短かった。
△:泡の保持時間がやや短かった。
〇:泡の保持時間が長かった。
◎:泡の保持時間が非常に長かった。
The foam retention time was determined as follows.
X: Bubble formation time was very short.
Δ: Bubble retention time was slightly short.
◯: The bubble retention time was long.
A: The foam retention time was very long.
泡の保持力は、以下のとおりの基準とした。
×:泡の保持力が非常に弱かった。
△:泡の保持力がやや弱かった。
〇:泡の保持力が強かった。
◎:泡の保持力が非常に強かった。
The foam retention strength was determined as follows.
X: The foam retention force was very weak.
Δ: The foam holding power was slightly weak.
◯: The foam retention was strong.
(Double-circle): The foam retention power was very strong.
総合評価は、以下のとおりの基準とした。
×:泡をあまり形成できず、泡のキメ細やかさ、泡の保持時間、及び泡の保持力の全体的なバランスが不十分であった。
△:泡は形成できるが、泡のキメ細やかさ、泡の保持時間、及び泡の保持力の全体的なバランスがやや不十分であった。
〇:泡を形成でき、泡のキメ細やかさ、泡の保持時間、及び泡の保持力の全体的なバランスが良好であった。
◎:泡を形成でき、泡のキメ細やかさ、泡の保持時間、及び泡の保持力の全体的なバランスが非常に良好であった。
The overall evaluation was based on the following criteria.
X: Foam could not be formed so much, and the overall balance of the fineness of the foam, the foam retention time, and the foam retention was insufficient.
(Triangle | delta): Although foam can be formed, the whole balance of the fineness of a foam, the retention time of a foam, and the retention power of a foam was a little inadequate.
◯: Bubbles could be formed, and the overall balance of the fine texture of the foam, the foam retention time, and the foam retention was good.
A: Bubbles could be formed, and the overall balance of the fine texture of the foam, the retention time of the foam, and the retention of the foam was very good.
実施例1〜5、比較例1、2に係るフォーム剤の処方及び評価結果を表1に示す。表1中の各数値は、各成分の「質量%」を示す。 Table 1 shows the formulations and evaluation results of the foams according to Examples 1 to 5 and Comparative Examples 1 and 2. Each numerical value in Table 1 indicates “mass%” of each component.
表1に示すように、増粘剤として多糖類のオクテニルコハク酸デンプンNaを含まない比較例1や閉鎖小胞体を含まない比較例2においては、泡のキメ細かやかさ、泡の保持時間、泡の保持力の評価が低かったのに対し、実施例1〜5においては、泡のキメ細かやかさ、泡の保持時間、泡の保持力の総合評価が良好であった。これにより、三相乳化物組成物に多糖類を加えることで、良好な泡を形成できることがわかった。 As shown in Table 1, in Comparative Example 1 that does not contain the polysaccharide octenyl succinate starch Na as a thickener and Comparative Example 2 that does not contain the closed endoplasmic reticulum, the fineness of the foam, the retention time of the foam, While the evaluation of the holding power was low, in Examples 1 to 5, the overall evaluation of the fineness of the foam, the holding time of the foam, and the holding power of the foam were good. Thereby, it turned out that a favorable foam can be formed by adding a polysaccharide to a three-phase emulsion composition.
<実施例6〜16>
(フォーム剤の調製)
まず、後述する表2に示すとおりに、上記実施例4とは、噴射剤(L−0.29)の量を変更した点以外は、同様の手順で実施例6〜12に係るフォーム剤を調製した。噴射剤としての液化ガスの種類をL−0.49(ブタンとプロパンとの混合ガス、20℃における圧力:0.49MPa)、L−0.39(ブタンとプロパンとの混合ガス、20℃における圧力:0.39MPa)、又はL−0.69(ブタンとプロパンとの混合ガス、20℃における圧力:0.69MPa)に変更した点以外は、実施例9と同様の手順で、後述する表3に示すとおり、実施例13、15、16に係るフォーム剤を調製した。噴射剤を液化ガスであるL−0.29から圧縮ガスであるCO2に変更した点以外は、上記実施例4と同様の手順で、後述する表3に示すとおり、実施例14に係るフォーム剤を調製した。
<Examples 6 to 16>
(Preparation of foam agent)
First, as shown in Table 2 described later, the foam agent according to Examples 6 to 12 was prepared in the same manner as in Example 4 except that the amount of the propellant (L-0.29) was changed. Prepared. The type of liquefied gas as a propellant is L-0.49 (mixed gas of butane and propane, pressure at 20 ° C .: 0.49 MPa), L-0.39 (mixed gas of butane and propane, at 20 ° C.) The pressure is 0.39 MPa) or L-0.69 (mixed gas of butane and propane, pressure at 20 ° C .: 0.69 MPa). As shown in 3, foaming agents according to Examples 13, 15, and 16 were prepared. But in this case changing the propellant from L-0.29 is liquefied gas to CO 2 is compressed gas, the same procedure as in Example 4, as shown in Table 3 to be described later, form according to Example 14 An agent was prepared.
(評価2)
実施例6〜16に係るフォーム剤について、「評価1」と同様の基準で泡のキメ細やかさ、泡の保持時間、泡の保持力の評価及び総合評価を行った。実施例6〜14に係るフォーム剤の処方及び評価結果を表2、3に示す。表3中の実施例14のCO2の項目は、圧縮ガスの25℃における圧力(MPa)を示す。
(Evaluation 2)
About the foam agent which concerns on Examples 6-16, evaluation of the fineness of foam, the retention time of foam, and the foam retention force and comprehensive evaluation were performed on the same criteria as “Evaluation 1”. Tables 2 and 3 show the formulations and evaluation results of the foams according to Examples 6 to 14. The item of CO 2 of Example 14 in Table 3 indicates the pressure (MPa) at 25 ° C. of the compressed gas.
表2、3に示すように、L−0.29の量が多い方が、泡の総合評価が高いことが示された。これは、増粘剤が水相に溶けており、水相の気化時に生じる泡が増粘剤の影響を受けるために、L−0.29の量が多い方が水相の気化時の勢いが強くなり、そのために泡の形成能が高くなり、結果的に泡の総合評価が良好となったためと推測される。また、L−0.29を用いた実施例9より実施例13、15、16の方が、泡の総合評価が高いことが示された。これはL−0.29よりL−0.49の方が圧力が高くて、L−0.29の量が多い方が水相の気化時の勢いが強くなり、そのために泡の形成能が高くなり、結果的に泡の総合評価が良好となったためと推測される。また、圧縮ガスを用いた実施例14より、液化ガスを用いた実施例の方が、全体的に泡の保持時間が高い傾向にあることが示された。これは、圧縮ガスが乳化組成物に溶ける量が少ないために、液化ガスに比べ水相の気化時の勢いが低い傾向にあることに起因すると推測される。 As shown in Tables 2 and 3, it was shown that the larger the amount of L-0.29, the higher the overall evaluation of the foam. This is because the thickener is dissolved in the aqueous phase, and the foam generated during the vaporization of the aqueous phase is affected by the thickener, so that the larger amount of L-0.29 is the momentum during the vaporization of the aqueous phase. This is presumably because the foam forming ability was increased, and as a result, the overall evaluation of the foam was improved. Moreover, it was shown that Example 13, 15, 16 has higher foam comprehensive evaluation than Example 9 using L-0.29. This is because the pressure of L-0.49 is higher than that of L-0.29, and the higher the amount of L-0.29, the stronger the moment of vaporization of the aqueous phase. It is estimated that it became higher and as a result, the overall evaluation of the foam was good. In addition, it was shown that the example using the liquefied gas tends to have a longer bubble retention time than the example 14 using the compressed gas. This is presumed to be due to the fact that the amount of the compressed gas dissolved in the emulsified composition is small, so that the momentum during vaporization of the aqueous phase tends to be lower than that of the liquefied gas.
<実施例17、18>
(フォーム剤の調製)
まず、上記実施例4とは、増粘剤の種類をタピオカデンプン又はアルギン酸Naに変更した点以外は、同様の手順で、後述する表4に示すとおりに、実施例17、18に係るフォーム剤を調製した。
<Examples 17 and 18>
(Preparation of foam agent)
First, the foam agent according to Examples 17 and 18 was the same as Example 4 except that the type of thickener was changed to tapioca starch or Na alginate as shown in Table 4 described later. Was prepared.
(評価3)
実施例17、18に係るフォーム剤について、「評価1」と同様の基準で泡のキメ細やかさ、泡の保持時間、泡の保持力の評価及び総合評価を行った。上述の実施例4、17、18に係るフォーム剤の処方及び評価結果を表4に示す。
(Evaluation 3)
About the foam agent which concerns on Examples 17 and 18, the fineness of foam, the retention time of foam, evaluation of foam retention, and comprehensive evaluation were performed on the same criteria as “Evaluation 1”. Table 4 shows the formulation and evaluation results of the foams according to Examples 4, 17, and 18 described above.
表4に示すように、オクテニルコハク酸デンプンNa、タピオカデンプン、アルギン酸類の全てにおいて、泡の総合評価が高かった。特に、アルギン酸Naを用いたときの泡の総合評価が優れていることがわかった。 As shown in Table 4, in all of octenyl succinate starch Na, tapioca starch, and alginic acids, the overall evaluation of foam was high. In particular, it was found that the overall evaluation of bubbles when Na alginate was used was excellent.
<実施例19〜22>
(フォーム剤の調製)
まず、上記実施例4とは、乳化に用いる三相乳化の粒子を、HCO−10(ポリオキシエチレン硬化ひまし油の誘導体)、HCO−30(ポリオキシエチレン硬化ひまし油の誘導体)、レシノール(水添レシチン)、又はヒドロキシエチルセルロースに変更した点以外は、同様の手順で、後述する表5に示すとおりに、実施例19〜22に係るフォーム剤を調製した。
<Examples 19 to 22>
(Preparation of foam agent)
First, in Example 4, the three-phase emulsified particles used for emulsification are HCO-10 (polyoxyethylene hydrogenated castor oil derivative), HCO-30 (polyoxyethylene hydrogenated castor oil derivative), and recinol (hydrogenated lecithin). ), Or the point except having changed to hydroxyethyl cellulose, the foam agent which concerns on Examples 19-22 was prepared in the same procedure as shown in Table 5 mentioned later.
(評価4)
実施例19〜22に係るフォーム剤について、「評価1」と同様の基準で泡のキメ細やかさ、泡の保持時間、泡の保持力の評価及び総合評価を行った。上述の実施例4、実施例19〜22に係るフォーム剤の処方及び評価結果を表4に示す。
(Evaluation 4)
About the foam agent which concerns on Examples 19-22, evaluation of the fineness of foam, the retention time of foam, evaluation of foam retention, and comprehensive evaluation were performed on the same criteria as “Evaluation 1”. Table 4 shows the formulation and evaluation results of the foams according to Example 4 and Examples 19 to 22 described above.
表5に示すように、実施例19〜22に係るフォーム剤の全てにおいて、良好な泡を形成できたことが示された。これにより、三相乳化粒子として、HCO−10(ポリオキシエチレン硬化ひまし油)、HCO−30(ポリオキシエチレン硬化ひまし油)、レシノール(水添レシチン)、又はヒドロキシエチルセルロースを用いても、良好な泡を形成できることがわかった。 As shown in Table 5, it was shown that good foams could be formed in all of the foam agents according to Examples 19-22. Thereby, even if HCO-10 (polyoxyethylene hydrogenated castor oil), HCO-30 (polyoxyethylene hydrogenated castor oil), resinol (hydrogenated lecithin), or hydroxyethyl cellulose is used as the three-phase emulsified particles, good foam is produced. It was found that it can be formed.
また、HCO−10の平均粒子径は500nmで、HCO−30の平均粒子径は20nmであった。実施例20が実施例19より評価が高かったのは、このように平均粒子径が小さくて、泡の発生に追従しやすく、泡形成しやすくなるためと推測される。 Moreover, the average particle diameter of HCO-10 was 500 nm, and the average particle diameter of HCO-30 was 20 nm. The reason why the evaluation of Example 20 was higher than that of Example 19 is presumed to be that the average particle diameter is small in this way, and it is easy to follow the generation of bubbles and to easily form bubbles.
<実施例23〜27>
(フォーム剤の調製)
油相に用いる油の種類を、メトキシケイヒ酸エチルヘキシル、シクロペンタシロキサン、又はエチルヘキサン酸セチルに変更した点以外は、上記実施例4と同様の手順で、後述する表6に示すとおりに、実施例23〜25に係るフォーム剤を調製した。
<Examples 23 to 27>
(Preparation of foam agent)
Except that the type of oil used in the oil phase was changed to ethylhexyl methoxycinnamate, cyclopentasiloxane, or cetyl ethylhexanoate, the same procedure as in Example 4 was performed as shown in Table 6 described later. Foams according to Examples 23 to 25 were prepared.
油相に用いる油を、コメヌカ油、オリーブ油、ホホバ油、及びアーモンド油の混合物に変更した点以外は、上記実施例4と同様の手順で、後述する表7に示すとおりに、実施例26に係るフォーム剤を調製した。後述する表7に示すとおりに、各成分の量を変更した点以外は、実施例26と同様の手順で実施例27に係るフォーム剤を調製した。 Except that the oil used in the oil phase was changed to a mixture of rice bran oil, olive oil, jojoba oil, and almond oil, the same procedure as in Example 4 above, as shown in Table 7 described later, in Example 26, Such a foam was prepared. As shown in Table 7 described later, a foam agent according to Example 27 was prepared in the same procedure as in Example 26 except that the amount of each component was changed.
(評価5)
実施例23〜27に係るフォーム剤について、「評価1」と同様の基準で泡のキメ細やかさ、泡の保持時間、泡の保持力の評価及び総合評価を行った。上述の実施例4、実施例23〜27に係るフォーム剤の処方及び評価結果を表6、7に示す。
(Evaluation 5)
About the foam agent which concerns on Examples 23-27, evaluation of the fineness of foam, the retention time of foam, evaluation of foam retention, and comprehensive evaluation were performed on the same criteria as “Evaluation 1”. Tables 6 and 7 show the formulations and evaluation results of the foams according to Example 4 and Examples 23 to 27 described above.
表6、7に示すように、スクワランのような炭化水素油のみでなく、メトキシケイヒ酸エチルヘキシル、エチルヘキサン酸セチルのようなエステル油、シクロペンタシロキサンのようなシリコーン油、コメヌカ油、オリーブ油、ホホバ油、アーモンドのような植物油においても、良好な泡を形成できたことが示された。特に、植物油を用いたときに、泡の総合評価が高いことがわかった。また、実施例27のように油全体の量を約30質量%と多くしても、良好な泡を形成できることがわかった。 As shown in Tables 6 and 7, not only hydrocarbon oils such as squalane, but also ester oils such as ethylhexyl methoxycinnamate and cetyl ethylhexanoate, silicone oils such as cyclopentasiloxane, rice bran oil, olive oil, jojoba It was shown that good foams could be formed even in vegetable oils such as oil and almond. In particular, it was found that the overall evaluation of foam was high when vegetable oil was used. Further, it was found that even when the total amount of oil was increased to about 30% by mass as in Example 27, good bubbles could be formed.
Claims (13)
前記重縮合ポリマーの粒子の平均粒径が8nm以上800nm以下である、請求項1から6のいずれかに記載の乳化組成物。 An average particle diameter of the closed vesicle formed of an amphiphile that spontaneously forms a closed vesicle is 8 nm or more and 800 nm or less;
The emulsified composition according to any one of claims 1 to 6, wherein the average particle diameter of the polycondensation polymer particles is 8 nm or more and 800 nm or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016168448A JP6865409B2 (en) | 2016-08-30 | 2016-08-30 | Emulsifying composition for producing foaming agents, foaming agents, methods for improving foam-forming power, foam-forming power improving agents, and cosmetic methods. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016168448A JP6865409B2 (en) | 2016-08-30 | 2016-08-30 | Emulsifying composition for producing foaming agents, foaming agents, methods for improving foam-forming power, foam-forming power improving agents, and cosmetic methods. |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018035082A true JP2018035082A (en) | 2018-03-08 |
JP6865409B2 JP6865409B2 (en) | 2021-04-28 |
Family
ID=61565408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016168448A Active JP6865409B2 (en) | 2016-08-30 | 2016-08-30 | Emulsifying composition for producing foaming agents, foaming agents, methods for improving foam-forming power, foam-forming power improving agents, and cosmetic methods. |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6865409B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019021801A1 (en) * | 2017-07-28 | 2019-01-31 | 学校法人神奈川大学 | External preparation for skin, and method for producing same |
CN112957279A (en) * | 2021-02-26 | 2021-06-15 | 广州米卡美妆有限公司 | Hydrogel particles and application thereof in preparation of personal care products |
JP7376020B2 (en) | 2018-04-25 | 2023-11-08 | 小池化学株式会社 | Emulsified composition for making aerosol for atomization, emulsified composition for making aerosol for sherbet |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005015365A (en) * | 2003-06-25 | 2005-01-20 | Koike Kagaku Kk | Aerosol type cleansing disinfectant |
JP2014005240A (en) * | 2012-06-26 | 2014-01-16 | Daizo:Kk | Foamable aerosol composition |
JP2016079107A (en) * | 2014-10-10 | 2016-05-16 | 学校法人神奈川大学 | Emulsion composition for making aerosol, and aerosol agent |
-
2016
- 2016-08-30 JP JP2016168448A patent/JP6865409B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005015365A (en) * | 2003-06-25 | 2005-01-20 | Koike Kagaku Kk | Aerosol type cleansing disinfectant |
JP2014005240A (en) * | 2012-06-26 | 2014-01-16 | Daizo:Kk | Foamable aerosol composition |
JP2016079107A (en) * | 2014-10-10 | 2016-05-16 | 学校法人神奈川大学 | Emulsion composition for making aerosol, and aerosol agent |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019021801A1 (en) * | 2017-07-28 | 2019-01-31 | 学校法人神奈川大学 | External preparation for skin, and method for producing same |
JPWO2019021801A1 (en) * | 2017-07-28 | 2020-07-16 | 学校法人神奈川大学 | Skin external preparation and method for producing the same |
JP7376020B2 (en) | 2018-04-25 | 2023-11-08 | 小池化学株式会社 | Emulsified composition for making aerosol for atomization, emulsified composition for making aerosol for sherbet |
CN112957279A (en) * | 2021-02-26 | 2021-06-15 | 广州米卡美妆有限公司 | Hydrogel particles and application thereof in preparation of personal care products |
Also Published As
Publication number | Publication date |
---|---|
JP6865409B2 (en) | 2021-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6339376B2 (en) | Cosmetics | |
CN101791277B (en) | Personal care sunscreen compositions having reduced eye irritation | |
JP6865409B2 (en) | Emulsifying composition for producing foaming agents, foaming agents, methods for improving foam-forming power, foam-forming power improving agents, and cosmetic methods. | |
KR20110102336A (en) | Personal care composition containing a volatile and a terpene alcohol | |
JP4681234B2 (en) | One-phase microemulsion composition and method for producing the same | |
JP6417181B2 (en) | Emulsion composition for aerosol preparation and aerosol agent | |
US9913786B2 (en) | Moisturizing composition which may be applied to wet skin in the form of an oil-in-water emulsion; moisturizing care process | |
JP2023029558A (en) | Oil-in-water emulsion composition, preparation method therefor and product | |
JP2005255669A (en) | Oil-in-water type sunscreen cosmetic | |
JP6036874B2 (en) | Cleansing composition and cleansing article | |
JP5778908B2 (en) | Oil-in-water emulsion composition | |
JP6792353B2 (en) | Water-in-oil emulsified composition | |
JP6976543B2 (en) | Foaming emulsifying composition, foaming composition, foaming material, method for improving foaming property, foaming property improving agent, and method for adjusting foam hardness. | |
JP6850599B2 (en) | Oil-in-water emulsified composition and external preparation for skin | |
US6890519B2 (en) | Silicone oil/cosolvent system concentrated in active liposoluble cosmetic substance(s), corresponding cosmetic emulsion and formulation | |
JP5656272B1 (en) | Cleansing composition and cleansing article | |
JP7376020B2 (en) | Emulsified composition for making aerosol for atomization, emulsified composition for making aerosol for sherbet | |
JP3765119B2 (en) | Highly water-containing oil-in-water emulsion composition and method for producing the same | |
JP4150280B2 (en) | High internal water phase oil-in-water emulsified cosmetic | |
CN105636574A (en) | Foamable personal care composition comprising a continuous oil phase | |
JPWO2019187703A1 (en) | Underwater oil drop type fine emulsion type cosmetics | |
JP6031182B1 (en) | Method for producing oil-in-water emulsion composition | |
JP2020121943A (en) | External preparation for skin and mucous membrane and method for producing the same and base material for external preparation for skin and mucous membrane | |
JP6792632B2 (en) | Emulsified cosmetics | |
KR102375497B1 (en) | cracking aerosol composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190801 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200515 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200707 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200902 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201105 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210323 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210326 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6865409 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |